Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |